Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.


The type 1 insulin-like growth factor receptor (IGF-1R) is a transmembrane glycoprotein composed of two extracellular alpha subunits and two beta subunits with tyrosine kinase activity. The IGF-1R is frequently upregulated in cancers and signals from the cell surface to promote proliferation and cell survival. Recent attention has focused on the IGF-1R as a target for cancer treatment. Here, we report that the nuclei of human tumor cells contain IGF-1R, detectable using multiple antibodies to alpha- and beta-subunit domains. Cell-surface IGF-1R translocates to the nucleus following clathrin-mediated endocytosis, regulated by IGF levels. The IGF-1R is unusual among transmembrane receptors that undergo nuclear import, in that both alpha and beta subunits traffic to the nucleus. Nuclear IGF-1R is phosphorylated in response to ligand and undergoes IGF-induced interaction with chromatin, suggesting direct engagement in transcriptional regulation. The IGF dependence of these phenomena indicates a requirement for the receptor kinase, and indeed, IGF-1R nuclear import and chromatin binding can be blocked by a novel IGF-1R kinase inhibitor. Nuclear IGF-1R is detectable in primary renal cancer cells, formalin-fixed tumors, preinvasive lesions in the breast, and nonmalignant tissues characterized by a high proliferation rate. In clear cell renal cancer, nuclear IGF-1R is associated with adverse prognosis. Our findings suggest that IGF-1R nuclear import has biological significance, may contribute directly to IGF-1R function, and may influence the efficacy of IGF-1R inhibitory drugs.

DOI: 10.1158/0008-5472.CAN-10-0052

1 Figure or Table

Citations per Year

1,203 Citations

Semantic Scholar estimates that this publication has 1,203 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Aleksic2010Type1I, title={Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.}, author={Tamara Aleksic and Meenali M. Chitnis and Olga V. Perestenko and Shan Gao and Peter H. Thomas and Gareth D. H. Turner and Andrew S. Protheroe and Mark Howarth and Valentine M. Macaulay}, journal={Cancer research}, year={2010}, volume={70 16}, pages={6412-9} }